Quince Therapeutics (QNCX) Presents At Canaccord Genuity 42nd Annual Growth Conference - Slideshow

Advancing innovative precision therapeutics for debilitating and rare diseases CANACCORD GENUITY 42ND ANNUAL GROWTH CONFERENCE A u g u s t 1 1 , 2 0 2 2 Forward-looking statements 2 Statements in this presentation contain "forward-looking statements" that are subject to substantial risks and uncertainties. Forward-looking statements contained in this presentation may be identified by the use of words such as "expect," "will," "estimate," "project," "potential," "positioned," "advancing," "planned," "progres ...